GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Omid Holdings Inc (OTCPK:OMID) » Definitions » EBITDA Margin %

Omid Holdings (Omid Holdings) EBITDA Margin % : 0.00% (As of . 20)


View and export this data going back to . Start your Free Trial

What is Omid Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Omid Holdings's EBITDA for the three months ended in . 20 was $0.00 Mil. Omid Holdings's Revenue for the three months ended in . 20 was $0.00 Mil. Therefore, Omid Holdings's EBITDA margin for the quarter that ended in . 20 was 0.00%.


Omid Holdings EBITDA Margin % Historical Data

The historical data trend for Omid Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Omid Holdings EBITDA Margin % Chart

Omid Holdings Annual Data
Trend
EBITDA Margin %

Omid Holdings Quarterly Data
EBITDA Margin %

Competitive Comparison of Omid Holdings's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Omid Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omid Holdings's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Omid Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Omid Holdings's EBITDA Margin % falls into.



Omid Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Omid Holdings's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (A: . 20 )/Revenue (A: . 20 )
=/
= %

Omid Holdings's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %=EBITDA (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Omid Holdings  (OTCPK:OMID) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Omid Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Omid Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Omid Holdings (Omid Holdings) Business Description

Traded in Other Exchanges
N/A
Address
1130 Springtown Road, Suite B, Phillipsburg, NJ, USA, 08865
Omid Holdings Inc is a health and wellness company. It is specialized in the sale and manufacture of CBD-based products. The company manufactures and sells branded inhalable, sublingual, and topical hemp-derived consumer goods. Its brands include Naturally Peaked Health, Shangri-La Life, and Peac Wellness. The company also offers design, development, manufacturing services to clients in the CBD-based cannabis industry.

Omid Holdings (Omid Holdings) Headlines

From GuruFocus

OMID Provides Third-Quarter Financial Highlights

By PRNewswire PRNewswire 10-12-2021

OMID Provides Corporate Update

By PRNewswire PRNewswire 01-07-2021

OMID Posts Third Quarter Financial Statements

By PRNewswire PRNewswire 11-09-2021

OMID Acquires Champ Life Brand

By PRNewswire PRNewswire 04-20-2021

OMID Launches New Products and Marketing

By PRNewswire PRNewswire 06-16-2020

OMID Makes Strategic Investment Into Psychedelic Medicine

By PRNewswire PRNewswire 08-12-2021

OMID Provides Third-Quarter Financial Results

By PRNewswire PRNewswire 10-16-2020

OMID Announces Reduction of Common Shares

By PRNewswire PRNewswire 06-24-2021

OMID Reports Strong Second-Quarter Financial Results

By PRNewswire PRNewswire 09-16-2020